Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMV Viremia”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableLooking for participantsNCT07294547
What this trial is testing

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Who this might be right for
Kidney Transplantation, Cytomegalovirus InfectionsEBV InfectionAntiviral Prophylaxis
National Taiwan University Hospital 80
Not applicableStudy completedNCT03443791
What this trial is testing

Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation

Who this might be right for
Cmv CongenitalCMV Viremia
University of Alabama at Birmingham 200
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Large-scale testing (Phase 3)Looking for participantsNCT07079735
What this trial is testing

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Who this might be right for
CMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection
Columbia University 150
Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Not applicableStudy completedNCT01883206
What this trial is testing

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

Who this might be right for
Viraemia
University College, London 48
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07379203
What this trial is testing

ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse

Who this might be right for
Cytomegalovirus (CMV) Infection
Wits Health Consortium (Pty) Ltd 130
Not applicableLooking for participantsNCT06339892
What this trial is testing

HCMV Breakthrough Infections During Letermovir Prophylaxis

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus ViremiaHematopoietic Stem Cell Transplantation
Fondazione IRCCS Policlinico San Matteo di Pavia 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07383649
What this trial is testing

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Who this might be right for
Brain Cancer MetastaticCMV Viremia
The Methodist Hospital Research Institute 28
Post-approval studies (Phase 4)Study completedNCT00947141
What this trial is testing

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Who this might be right for
Viraemia
University College, London 165
Not applicableUnknownNCT04320303
What this trial is testing

CMV Infection and Immune Intervention After Transplantation

Who this might be right for
CMV ViremiaTransplantation Infection
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01329185
What this trial is testing

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

Who this might be right for
EBV ViremiaCMV Viremia
University of Minnesota 17
Early research (Phase 1)Not Yet RecruitingNCT07020533
What this trial is testing

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 46
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Testing effectiveness (Phase 2)Looking for participantsNCT06059391
What this trial is testing

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center 216
Not applicableUnknownNCT03858907
What this trial is testing

Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV

Who this might be right for
Cytomegalovirus InfectionsCMVKidney Transplant Infection
University of Sao Paulo General Hospital 180
Not applicableStudy completedNCT02784756
What this trial is testing

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 134
Testing effectiveness (Phase 2)Study completedNCT04018261
What this trial is testing

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Who this might be right for
CMV ViremiaImmunosuppression-related Infectious Disease
Banc de Sang i Teixits 26
Not applicableActive Not RecruitingNCT07015801
What this trial is testing

CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

Who this might be right for
Cytomegalovirus ViremiaCytomegalovirus PneumoniaT-Lymphocyte Immunodeficiency
University of Calgary 1
Load More Results